C.M. Bidwell & Associates’s Incyte INCY Stock Holding History

C.M. Bidwell & Associates’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$242K	Sell	2,136 -65	-3%	-$6.45K	0.1%	134
2026 Q1	$207K	Hold	2,201	–	–	0.1%	135
2025 Q4	$217K	Buy	2,201 +260	+13%	+$25.2K	0.1%	128
2025 Q3	$165K	Buy	+1,941	New	+$153K	0.08%	148
2023 Q4	–	Sell	-1,695	Closed	-$97.9K	–	531
2023 Q3	$97.9K	Buy	+1,695	New	+$107K	0.07%	235
2019 Q4	–	Sell	-4,700	Closed	-$349K	–	425
2019 Q3	$349K	Buy	+4,700	New	+$380K	0.35%	84
2017 Q2	–	Sell	-16,695	Closed	-$2.23M	–	352
2017 Q1	$2.23M	Sell	16,695 -17,570	-51%	-$2.24M	0.5%	81
2016 Q4	$3.44M	Buy	+34,265	New	+$3.34M	0.81%	67

Other funds holding INCY

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

C.M. Bidwell & Associates's INCY Position: Q2 2026 in Review

C.M. Bidwell & Associates reduced its Incyte (INCY) stake by 3% in Q2 2026, selling an estimated $6.45K and leaving 2,136 shares worth $242K. The position accounts for 0.1% of the portfolio, ranked #134.

C.M. Bidwell & Associates first reported a position in INCY in Q4 2016 and has held it in 8 quarters since. The position peaked at $3.44M in Q4 2016. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

C.M. Bidwell & Associates held 2,136 shares of Incyte worth $242K as of Q2 2026.
C.M. Bidwell & Associates sold 65 Incyte shares in Q2 2026, an estimated $6.45K.
Incyte made up 0.1% of C.M. Bidwell & Associates's portfolio in Q2 2026, its #134 holding.
C.M. Bidwell & Associates first reported a position in Incyte in Q4 2016 and has held it in 8 quarters since.
C.M. Bidwell & Associates's Incyte position peaked at $3.44M in Q4 2016.
859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.